@article{HBSN25249,
author = {Carrie R. Wong and Joseph K. Lim},
title = {Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {8},
number = {5},
year = {2019},
keywords = {},
abstract = {Hepatocellular carcinoma (HCC) has one of the fastest growing rates of cancer-related incidence and mortality in the United States (U.S.) (1-3). From 2009 to 2013, the average annual percent change (AAPC) for liver cancer incidence became the highest among other reported cancers for both males (+2.9%) and females (+3.8%) (1). In addition, cancer-related mortality rates for liver cancer are the highest among solid malignancies from 2010 to 2014 for males (+2.6%) and females (+3.0%) (1). Morbidity and mortality from HCC are expected to increase, predominantly driven by an increasing prevalence of HCV-associated cirrhosis and non-alcoholic fatty liver disease (NAFLD) (2).},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/25249}
}